##semicolon##
viral hepatitis B; viral hepatitis C; care cascade; regional differences; Karakalpakstan.##submission.citations##
1. Botheju W.S.P., Zghyer F., Mahmud S. et al. The epidemiology of hepatitis C virus in Central Asia: systematic review, meta-analyses, and meta-regression analyses // Scientific Reports. 2019. Vol. 9. Art. 2090. DOI: https://doi.org/10.1038/s41598-019-38853-8
2. Davlidova S., Haley-Johnson Z., Nyhan K. et al. Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: a systematic review // International Journal of Infectious Diseases. 2021. Vol. 104. P. 510–525. DOI: https://doi.org/10.1016/j.ijid.2020.12.068
3. Isakov E.I., Khodjaeva M.E., Khikmatullaeva A.S. et al. Hepatitis B and D burden in Uzbekistan: comprehensive analysis of seroprevalence and risk correlates from a countrywide study // Infectious Diseases of Poverty. 2026. Vol. 15. Art. 88. DOI: https://doi.org/10.1186/s40249-026-01487-w
4. Ismoilov U.Y., Musabaev E.I., Khikmatullaeva A.S. et al. Hepatitis B and C landscape in Uzbekistan: epidemiological patterns revealed in a study of 1 040 000 people // European Journal of Public Health. 2025. Vol. 35, No. 5. P. 1014–1019. DOI: https://doi.org/10.1093/eurpub/ckaf136
5. Kamali I., Shumbusho F., Barnhart D.A. et al. Time to complete hepatitis C cascade of care among patients identified during mass screening campaigns in rural Rwanda: a retrospective cohort study // BMC Infectious Diseases. 2022. Vol. 22. Art. 272. DOI: https://doi.org/10.1186/s12879-022-07271-z
6. Musabaev E., Tohme R.A., Joldasova E. et al. Prevalence and epidemiology of hepatitis B and hepatitis D in Uzbekistan—results from a population-based serosurvey, 2022 // IJID Regions. 2026. Vol. 19. Art. 100910. DOI: https://doi.org/10.1016/j.ijregi.2026.100910
7. Nurmanova B. Reporting of progress toward eliminating viral hepatitis B and C in the Central Asian region // Advanced Gut & Microbiome Research. 2024. Art. 4818435. DOI: https://doi.org/10.1155/2024/4818435
8. Razavi-Shearer D. et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study // The Lancet Gastroenterology & Hepatology. 2018. Vol. 3, No. 6. P. 383–403. DOI: https://doi.org/10.1016/S2468-1253(18)30056-6
9. Resolution of the President of the Republic of Uzbekistan No. PP-243 of 16 May 2022 "On improving measures to counter the spread of certain topical viral infections". URL: https:// president.uz/ru/lists/view/5203
10. Shadaker S., Joldasova E., Tohme R.A. et al. Prevalence and epidemiology of hepatitis C in Uzbekistan: results from a population-based serosurvey, 2022 // IJID Regions. 2026. Vol. 20. Art. 100968. DOI: https://doi.org/10.1016/j.ijregi.2026.100968
11. Stanaway J.D. et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013 // The Lancet. 2016. Vol. 388, No. 10049. P. 1081–1088. DOI: https://doi.org/10.1016/S0140-6736(16)30579-7
12. Takahashi K. et al. Hepatitis C virus molecular epidemiology in Uzbekistan // Journal of Medical Virology. 2003. DOI: https://doi.org/10.1002/jmv.10298
13. Tohme R.A., Shadaker S., Joldasova E. et al. Awareness, knowledge, and practices related to hepatitis B and hepatitis C in the Republic of Uzbekistan — results from a population-based survey, 2022 // BMC Public Health. 2026. Vol. 26. Art. 628. DOI: https://doi.org/10.1186/s12889-025-25990-1
14. World Health Organization. Global Hepatitis Report 2024. Geneva: WHO; 2024. URL: https://www.who.int/publications/i/item/9789240091672
15. Yousaf M. et al. Prevalence of chronic hepatitis B virus infection among children in Uzbekistan: impact of vaccination // Vaccine. 2025. Vol. 48. Art. 126743. DOI: https://doi.org/10. 1016/j.vaccine.2025.126743